Peripheral Vascular Devices | Market Insights | Asia Pacific | 2023
Following the short-term negative impact of the COVID-19 pandemic on the Asia Pacific peripheral vascular device market, the high prevalence of PAD in the region, an expanding patient population, growth in endovascular procedure volumes, and rising adoption of premium-priced devices such as DCBs and DES will support continued growth in the Asia Pacific PV device market; however, cost constraints in the region’s publicly funded healthcare systems and limited reimbursement continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the Asia Pacific region from 2019 through 2031.
